Skip to main content

Table 1 Demographic and clinical characteristics in patients with cryptococcal meningitis

From: The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study

Variables All (N = 150)
(n,%)
Good outcome (N = 94)
(n,%)
Bad outcome (N = 56)
(n,%)
P-value
Male 98 (65.33) 58 (61.70) 40 (71.43) 0.288
Age
  ≤ 30 31 (20.67) 26 (27.66) 5 (8.93) 0.000
 31–60 91 (60.67) 59 (62.77) 32 (57.14)
 >60 28 (18.67) 9 (9.57) 19 (33.93)
Presenting symptoms and signs
 Headache 136 (90.67) 89 (94.68) 47 (83.93) 0.029
 Vomiting 78 (52.00) 46 (48.94) 32 (57.14) 0.331
 Fever 74 (49.33) 52 (55.32) 22 (39.29) 0.057
 Altered mentation 31 (20.67) 12 (12.77) 19 (33.93) 0.002
 Abnormal vision 29 (19.33) 20 (21.28) 9 (16.07) 0.435
 Cough 12 (8.00) 7 (7.45) 5 (8.93) 0.746
 Abnormal hearing 9 (6.00) 5 (5.32) 4 (7.14) 0.726
 Seizure 7 (4.67) 4 (4.26) 3 (5.36) 1.000
Underlying diseases or factors
 HIV infection 32 (21.33) 8 (8.51) 24 (42.86) 0.000
 Immune system disease 16 (10.67) 12 (12.77) 4 (7.14) 0.413
 Hepatobiliary diseases 14 (9.33) 11 (11.70) 3 (5.36) 0.170
 Hypertension 13 (8.67) 9 (9.57) 4 (7.14) 0.768
 Corticosteroid medication or immunosuppressive drugs 15 (10.00) 9 (9.57) 6 (10.71) 0.822
 Diabetes mellitus 12 (8.00) 9 (9.57) 3 (5.36) 0.536
 Chronic lung disease 6 (4.00) 4 (4.26) 2 (3.57) 1.000
 Renal transplantation 7 (4.67) 4 (4.26) 3 (5.36) 1.000
 Tuberculosis 6 (4.00) 1 (1.06) 5 (1.79) 0.027
 Others 26 (17.92) 15 (15.96) 11 (19.64) 0.564
 None 32 (21.97) 25 (26.60) 7 (12.50) 0.042